ABSTRACT: One-pot synthesis of 3,5-disubstituted 1,2,4-oxadiazoles from carboxylic acids and nitriles was optimized to parallel chemistry. The method was validated on a 141 member library; the desired products were recovered with a high success rate and in moderate yields. Practical application of the approach was demonstrated in the synthesis of bioactive compound pifexole and agonists of free fatty acid receptor 1. A library of 4 948 100 synthesizable drug-like 3,5-disubstituted 1,2,4-oxadiazoles was enumerated based on the method and available validated reagents. KEYWORDS: one-pot parallel synthesis, 1,2,4-oxadiazoles, nitriles, carboxylic acids, readily accessible (REAL) arrays H igh-throughput screening (HTS) has been a valuable tool in many drug discovery projects.
H igh-throughput screening (HTS) has been a valuable tool in many drug discovery projects. 1 To expect high efficiency of HTS, one requires sized libraries of structurally diverse compounds with favorable physicochemical profiles. The libraries are typically delivered by parallel chemistry. Discovering new parallel synthesis procedures and optimizing to the parallel conditions known "flask" chemistry protocols, therefore, have been among important goals in facilitating success for drug discovery projects. Additionally, new parallel chemistry allows for expanding a synthetically accessible area within a virtual chemical space.
For 25 years, we have been participating in the Escape of virtual space by introducing approaches to the compounds widely exploited in HTS, 2−5 sulfonamides, 6 ureas, 7 secondary amines, 8, 9 to name a few. The key point of our research has been to deliver a simple, cost-effective, and highly feasible parallel chemistry. This goal in part correlates with the guidelines for the "ideal synthesis" suggested by Wender 10 and has been achieved by applying the following criteria to the procedures under development: (i) price, availability, and compatibility of reagents; (ii) simplicity of reaction setup and workup manipulations; (iii) applicability to a wide range of substrates.
A recent project on antidiabetics performed by our biological department was to find agonists of free fatty acid receptor 1 (GPR40). 11 A cell-based HTS identified hits with a hitherto unknown for this target 1,2,4-oxadiazole motif which lack instock analogs for hit follow-up. This pushed us to establish parallel chemistry approach to these compounds. Indeed, 3,5-disubstituted 1,2,4-oxadiazoles have been widely exploited in medicinal chemistry; 12−14 the motif is found in experimental and marketed drugs (Figure 1) , 15, 16 and has an acceptable ADME profile. 17 A literature search revealed several "flask" chemistry approaches to assemble the 3,5-disubstituted 1,2,4-oxadiazole ring. 18−25 To our surprise, some of these methods have been proposed only recently, 21 ,23−25 after more than 120 years since the first discovery of 1,2,4-oxadiazoles, 26 that indicates a growing interest for this motif. The parallel synthesis, however, has been reported only for the 4 + 1 assembly reaction between amidoximes and carboxylic acids (Figure 2) . 18−20 But this approach had a limitation: amidoximes (254) were scarcely represented in our stock compared with carboxylic acids (15 886) ( Figure 2 ) that is a general trend for the former reagents. 27 The method from amidoximes and carboxylic acids, therefore, would result in low diversity libraries and ineffective exploration of chemical space. Additional features of amidoximes: instability and relatively high price, made these reagents unfavorable in parallel chemistry.
After close examination of the other "flask" procedures, we chose the approach from nitriles and carboxylic acids. Nitriles are more stable and less expensive reagents than amidoximes. Indeed, our 4061 in-stock nitriles would support high variation of the substituents at the C(3) position of the ring thus affording more diverse libraries than the in-stock amidoximes. But the reported "flask" procedure 21 from nitriles and carboxylic acids was not suitable for parallel chemistry: (a) a solvent-free setup would complicate mixing for the reactions on a submillimolar scale; (b) acetate anion of the catalyst, 4-(dimethylamino)pyridinium acetate, could react concurrently with amidoximes resulting in side products, 5-methyl 1,2,4-oxadiazoles; and (c) scope and limitations of the procedure had not been assessed as the tested reagents were limited to the phenyl-containing substrates.
Herein, we present our results on the adaptation of the approach from nitriles and carboxylic acids to the parallel conditions and on its application to various substrates including GPR40 agonists. We also discuss the usefulness of the developed method on exploring synthesizable chemical space.
Modification of the Method from Nitriles and Carboxylic Acids to the Parallel Conditions. Most multistep millimolar-or submillimolar-scale reactions, we have previously established for the parallel chemistry, have a simple one-pot setup that employs 8 mL sealed vials as the reactors and a shaker or an oven shaker for mixing or mixing with heating, respectively. To enable this setup, one should account for solubility and efficiency of reagents and intermediates, solubility of byproducts, and compatibility of solvents. The assembly of 3,5-disubstituted 1,2,4-oxadiazoles from nitriles and carboxylic acids is a three-step procedure: (1) a generation of an amidoxime in situ, (2) a condensation of the amidoxime with a carboxylic acid to form an O-acylamidoxime, and (c) a cyclodehydration of the Oacylamidoxime. A closer examination of these transformations revealed that the procedure did not need special reaction conditions, for example, dropwise addition of reagents, maintaining low temperature or inert atmosphere, and would proceed at room or elevated temperatures. Thus, we set the reactions in an oven shaker ( Figure S1 ).
The "flask" synthesis of amidoximes from nitriles and hydroxylammonium chloride (NH 2 OH·HCl) has been conducted in methanol or ethanol in the presence of a base, 28−31 that is, NaOH, Na 2 CO 3 , K 2 CO 3 , and triethylamine (TEA). We chose ethanol for the amidoxime generation as this solvent supported mild heating to achieve efficient conversion of the reagents and could help remove water by azeotropic distillation. We found TEA, an inexpensive ($70/L) and mild base, the most appropriate reagent for this step. TEA and its hydrochloride are soluble in ethanol while other bases from the list have poor solubility and might prevent efficient mixing in small volumes. This base was also sufficient to promote the cylcodehydration of O-acylamidoximes. Our previous experience in the acylation reactions revealed a combination of N-(3-(dimethylamino)-propyl)-N′-ethylcarbodiimide (EDC) and 1-hydroxy-7-aza-1H-benzotriazole (HOAt) as the most efficient condensing agent. EDC 32 has been widely employed in the synthesis of drug candidates; 33 HOAt 34 is an epimerization suppressant, a safe and more stable analogue of 1-hydroxybenzotriazole (HOBt). These reagents 35 support acylation even with electron deficient carboxylic acids and tolerate aqueous workup because unreacted EDC, N-(3-(dimethylamino)propyl)-N′-ethyl urea (the byproduct from EDC), and HOAt are water-soluble. The acylation reaction occurs at room temperature but the following cylcodehydration of the O-acylamidoxime required elevated temperatures of 100−120°C. So, we chose DMF as a solvent for these steps.
We compared the designed three-step procedure from nitriles and carboxylic acids to the known two-step approach from amidoximes and carboxylic acids. For the test experiments, we selected from our stock seven amidoximes ( Figure 3 , chemset 1a), the corresponding nitriles (chemset 1n), and 14 carboxylic acids ( Figure 4 , chemset 2). Then, we performed 40 randomly chosen parallel reactions on a millimolar scale (20 from the amidoximes, method A, and 20 from the nitriles, method B, Table 1 , chemset 3). The synthesis of the full combinatorial set (98 members, 196 reactions) was unnecessary for the method development. We ran the experiments in a semiparallel mode monitoring each step by LC-MS or NMR to ensure that the chosen conditions were optimal. Briefly, we prepared amidoximes (first step in method B) as follows: a mixture of a nitrile 1n (1 equiv), NH 2 OH·HCl (1.5 equiv), and TEA (2 equiv) in ethanol was shaken in a sealed vial at room temperature for 6 h and at 70°C for 16 h. The solvent was subsequently removed in vacuum. The aforementioned conditions were sufficient to achieve full conversion of the nitriles. The amidoximes were (Table 1) : the aqueous workup afforded pure compounds (>90% product content) in most of the experiments. The product content was higher in the two-step reactions (>75%) than those in the three-step ones (>65%, Figures S2− S7). The mixtures with product content below 90% were subjected to reversed phase HPLC; identity and purity of the synthesized compounds were confirmed by 1 H, 13 C NMR and LC-MS. Not surprisingly, the isolated yields were also higher for method A than those for method B. This fact, however, had a minor influence on selection of the method for parallel chemistry because the determining factors are availability, variety, and price of the reagents (Table 1) . Nonetheless, the three-step procedure afforded 3,5-disubstituted 1,2,4-oxadiazoles in sufficient quantities (>50 mg) for biochemical assays.
Evaluation of the Method. Next step in the development process is the application of the established approach to produce at least a 100 member set. The substrates, randomly selected from our stock, included reagents with different reactivity and those with additional functionalities. In the case of 1,2,4-oxadiazoles, we probed combinations of nitriles and carboxylic acids to generate 3-alkyl-5-alkyl-, 3-alkyl-5-aryl-, 3-aryl-5-aryl-, and 3-aryl-5-alkyl-derivatives. We chose 30 nitriles (Figures S8  and S9 ) and 23 carboxylic acids (Figures S10 and S11) with attractive medicinal chemistry motifs and set up 120 parallel reactions on millimolar and submillimolar (0.2 mmol) scale utilizing method B (41 examples are included in the paper, Tables 2−5, chemsets 3.1−3.4). The subsequent workup and isolation afforded products in moderate yields identity and purity of the compounds were validated by NMR and LC-MS. Most reagents and especially those with additional functionalities were tolerated under the reaction conditions (for example, 3{3,1}, 3.2{8,10}, and 3.4{7,10}). Among the synthesized compounds, a known bioactive substance pifexole, 5-(2-chlorophenyl)-3-(pyridin-4-yl)-1,2,4-oxadiazole, was isolated in a 55% yield (entry 8 in Table 4 ) that is on par with the previously reported method from the corresponding amidoxime (71% if the amidoxime preparation and isolation step is included). 13, 36, 37 Overall, the products were recovered with 82% success rate, an acceptable value for a three-step three-component process. Thus, the developed method met all requirements of parallel chemistry: high success rate, simplicity, and applicability.
The applicability factor reveals the major difference between the "ideal" and the parallel synthesis: in the latter methodology the yields are far from being quantitative. Indeed, parallel chemistry is aimed to produce sized screening compound libraries in short periods of time and in suboptimal yields rather than to spend resources on optimization of the reaction conditions and thus obtain fewer compounds in high yields.
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This trend is supported by recent modernization of screening techniques and assays resulted in minimization of material required for HTS and by introduction of approaches to screen crude mixtures. 39 Synthesis of GPR40 Agonists. We utilized the developed procedure to prepare precursors for the project focused on the search for potential agonists of GPR40:14 derivatives of chloroacetic or 1-chloropropionic acids were synthesized and further modified to afford 21 1,2,4-oxadiazoles. The cell-based assay conducted on these compounds revealed micromolar to submicromolar potency for most studied 1,2,4-oxadiazoles, pharmacokinetic experiments proved selectivity against other GPRs and favorable ADME profiles ( Figure S12 ).
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Charting a Feasible Region in a Virtual Chemical Space. High-throughput virtual screening (HTVS) has provided a valuable support to HTS at the early stages of many drug discovery projects. Recent improvements in molecular docking has enabled effective hit identification thus making HTVS an alternative to HTS. 41, 42 The major difference between two screening strategies is that HTVS is not limited to the compounds on hand and allows virtual structures. The use of virtual sets greatly expands a screenable space but also raises an important question: which virtual compounds can be actually made for biochemical evaluation?
To address this question, we have developed readily accessible (REAL) arrays. The structures included in REAL arrays are indeed highly feasible because (i) they are made of only in-stock reagents caref ul selected based on the years of experience in synthetic organic and parallel chemistry and (ii) they are made by applying only in-house established and validated transformations.
These features distinct REAL arrays from similar virtual databases 43, 44 making them a pool of readily synthesizable molecules extracted from the virtual chemical space.
A classical combinatorial approach gave 4061 × 15 886 = 64 513 046 theoretically possible 3,5-disubstituted 1,2,4-oxadiazoles. Applying to this virtual space the REAL criteria (>12 g of in-stock available tested substrates, reactivity clash), drug-like criteria, 45, 46 and PAINS filtering, 47 we generated 4 948 100 feasible molecules, a 4.9 M set.
To show utility of the 4.9 M set to drug discovery, we analyzed its overlap with 1073 drug-like bioactive (activity 10 μM or better) and 31 009 in-stock 1,2,4-oxadiazoles 48 using principal components analysis. Since the 4.9 M set was too large for processing, we reduced it to a 49K representative sample 49 (1%, 49 481 molecules) that respected the heterogeneity of the 4.9 M set ( Figure S13 ). The analysis revealed substantial overlap in both cases ( Figure 5 ) that made the REAL set a tool for structure−activity relationship studies or for hit follow-up. Additionally, many molecules from the representative sample occupied the space where the known compounds are absent indicating potentially novel molecules.
We compared the 4.9 M set with the bioactive and drug-like instock 1,2,4-oxadiazoles in more details: for each compound from the 4.9 M set, the distance to the nearest bioactive or the in-stock compound was calculated employing ECFP4 fingerprints 50 (Figures S14). For the bioactive, the distribution of similarity is centered around a Tanimoto score of 0.35. Most feasible compounds were novel compared to the bioactive set: 10% had a Tanimoto score >0.5, which is known as a good discriminative cutoff between similar and dissimilar molecules for ECFP4 fingerprint. Not all entries from the bioactive set had similar f e a s i b l e c o m p o u n d s : f o r e x a m p l e , G r -1 7 5 7 3 7 (ZINC000000006638) that hits Histamine H 3 receptor 51 had more than 350 analogues ( Figure 6 ) while Taniplon (ZINC000000010613) that is a GABA A receptor agonist, 52 none. Indeed, almost 65% of the bioactive compounds had at least one feasible 1,2,4-oxadiazole. For the in-stock 1,2,4-oxadiazoles, the distribution of similarity is centered around a Tanimoto score of 0. 45 showing that most of the feasible compounds are novel. These results correlated with the PCA positioning the 4.9 M set as a source for finding analogues and novel chemical entities. In conclusion, we established a facile one-pot parallel synthesis approach to 3,5-disubstituted 1,2,4-oxadiazoles. Verification on a set of 141 reactions (61 are presented in the paper) applying millimolar or submillimolar conditions showed that the approach completely satisfied the parallel synthesis criteria: (1) It is based on the starting reagents available as numerous collections from commercial sources that would support good alteration of the substituents at the third and the fifth positions of the 1,2,4-oxadiazole ring; (2) it had a simple setup utilizing general labware, an oven shaker, and a simple workup, extraction; (3) it could be applied to various reagents and tolerate additional functionalities.
The method was employed in the synthesis of bioactive compound pifexole and in the synthesis of precursors for novel GPR40 agonists.
The procedure was included in readily accessible (REAL) arrays that resulted in 4 948 100 feasible 3,5-disubstituted 1,2,4-oxadiazoles. The 4.9 M set contains analogues of the known bioactive 1,2,4-oxadiazoles and novel chemical entities.
We believe that our approach will be helpful for researchers who look for a simple and quick access to sized libraries of 3,5-disubstituted 1,2,4-oxadiazoles and are ready to employ parallel chemistry for achieving the goal.
■ EXPERIMENTAL PROCEDURES
General. All chemicals and solvents were obtained from Enamine Ltd and used without further purification. NMR spectra were acquired on Bruker Avance DRX 400 and Bruker Avance DRX 500 spectrometers using DMSO-d 6 as a solvent and tetramethylsilane (TMS) as an internal standard. IR spectra were recorded on PerkinElmer Spectrum BX II. Elemental analysis was performed on a Vario MICRO Cube elemental microanalyzer (Elementar). Melting points were determined on Buchi melting point apparatus and are reported as uncorrected. LC-MS data were acquired on Agilent 1100 HPLC system equipped with diodematrix and mass-selective detector, column: Zorbax SB-C18, 4.6 mm × 15 mm. Eluent, A, acetonitrile−water with 0.1% of TFA (95:5); B, water with 0.1% of TFA. Crude samples with product content below 90% were purified with mass-triggered Agilent 1200 HPLC systems utilizing various gradients depending on a ClogP value of a particular compound. Principal Components Analysis (PCA). Representative REAL (49K), drug-like active, and in-stock available 1,2,4-oxadiazoles from ZINC15 database were compared utilizing PCA function as implemented in Data Warrior software. 35 Seven molecular descriptors were included: molecular weight, logP, number of H-bond donors, number of H-bond acceptors, number of rotatable bonds, topological polar surface area, and molecular complexity.
One-Pot Parallel Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazoles from Amidoximes and Carboxylic Acids (Method A). A mixture of thiophene-2-amidoxime 1a{2} (1 mmol), 2-(3-methyl-2-oxopyridin-1(2H)-yl)acetic acid 2{5} (1 mmol), EDC (1.5 mmol), and HOAt (0.7 mL of 20 wt % solution in DMF) was shaken at room temperature for 24 h. The cyclodehydration was performed in the presence of triethylamine (1 mmol) by heating the reaction vial at 100°C for 3 h. Then, 3 mL of water was added and the mixture was extracted with CHCl 3 . The chloroform phase was washed with water thrice and evaporated to afford 3-methyl-1-((3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)methyl)pyridin-2(1H)-one 3{2,5} as yellowish solid. One-Pot Parallel Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazoles from Nitriles and Carboxylic Acids (Method B). A mixture of thiophene-2-carbonitrile 1n{2} (1 mmol), NH 2 OH·HCl (1.5 mmol), and TEA (2 mmol) in ethanol was shaken in a sealed 8 mL vial at room temperature for 6 h. Then, the reaction mixture was heated at 70°C for 16 h. The solvent was removed after the heating utilizing a rotary evaporator. To the in situ formed amidoxime, 2-(3-methyl-2-oxopyridin-1(2H)-yl)acetic acid 2{5} (1 mmol), EDC (1.5 mmol), and 0.7 mL of 20 wt % HOAt in DMF were added and the mixture was shaken at room temperature for 24 h. The cyclodehydration was performed in the presence of triethylamine (1 mmol) by heating the reaction vial at 100°C for 3 h. Then, 3 mL of water was added and the mixture was extracted with CHCl 3 . The chloroform phase was washed with water thrice and evaporated. Yield: 180 mg, 66%. The essentially identical conditions were applied to the remaining compounds from chemset 3 when synthesized from nitriles. For the reactions on a submillimolar scale, the amounts of reagents were scaled down accordingly. 
